Our analyses showed higher expression of NORAD (Log2FC = 0.2541, p = 2.31 × 10−5) and RALGAPB (Log2FC = 0.3526, p = 5.96 × 10−11) in Lum A when compared to non-tumor samples and lower expression in Basal-like-NORAD (Log2FC = −0.2506, p = 4.664 × 10−4) and RALGAPB (Log2FC = −0.1533, p = 1.54 × 10−2) when compared to non-tumor samples. The gene discussed is RALGAPB; the disease is neoplasm.